| __timestamp | Incyte Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 347523000 | 855506000 |
| Thursday, January 1, 2015 | 479514000 | 996170000 |
| Friday, January 1, 2016 | 581861000 | 1047690000 |
| Sunday, January 1, 2017 | 1326361000 | 1324625000 |
| Monday, January 1, 2018 | 1197957000 | 1416476000 |
| Tuesday, January 1, 2019 | 1154111000 | 1754540000 |
| Wednesday, January 1, 2020 | 2215942000 | 1829537000 |
| Friday, January 1, 2021 | 1458179000 | 3051100000 |
| Saturday, January 1, 2022 | 1585936000 | 2540300000 |
| Sunday, January 1, 2023 | 1627594000 | 3162900000 |
| Monday, January 1, 2024 | 2606848000 | 3630300000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Vertex Pharmaceuticals Incorporated and Incyte Corporation have demonstrated significant commitment to R&D, with Vertex consistently outpacing Incyte in investment.
From 2014 to 2023, Vertex's R&D expenses surged by approximately 270%, peaking in 2023 with a remarkable 3.16 billion USD. In contrast, Incyte's R&D spending grew by about 370%, reaching 1.63 billion USD in the same year. Notably, Vertex's investment in 2021 was nearly double that of Incyte, highlighting its aggressive pursuit of new therapies.
This trend underscores the strategic importance of R&D in the biotech sector, where innovation is the key to staying ahead. As these companies continue to invest heavily, the future of medical breakthroughs looks promising.
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Incyte Corporation or Madrigal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Incyte Corporation and Opthea Limited
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Incyte Corporation vs Bausch Health Companies Inc.